CANNABIS POLAND AB ZY-10
Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more
CANNABIS POLAND AB ZY-10 (8TE) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CANNABIS POLAND AB ZY-10 - Net Assets Trend (None–None)
This chart illustrates how CANNABIS POLAND AB ZY-10's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CANNABIS POLAND AB ZY-10 (None–None)
The table below shows the annual net assets of CANNABIS POLAND AB ZY-10 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CANNABIS POLAND AB ZY-10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CANNABIS POLAND AB ZY-10 Competitors by Market Cap
The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MTI Investment SE
ST:MTI
|
$824.01K |
|
VS_VISERVE ENTERPRISE
BK:VS
|
$824.65K |
|
Chijet Motor Company, Inc. Ordinary Shares
NASDAQ:CJET
|
$824.78K |
|
Robeco Sust Global Stars Eqs Fd – EUR E
AS:ROBA
|
$824.86K |
|
Microwave Filter Company Inc
PINK:MFCO
|
$823.62K |
|
Malpac Holdings Bhd
KLSE:4936
|
$822.83K |
|
Sharps Technology Inc. Warrant
NASDAQ:STSSW
|
$822.83K |
|
DAINIPPON SCREEN
BE:DAO
|
$822.43K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CANNABIS POLAND AB ZY-10's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CANNABIS POLAND AB ZY-10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CANNABIS POLAND AB ZY-10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CANNABIS POLAND AB ZY-10's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CANNABIS POLAND AB ZY-10 (8TE) | €- | N/A | N/A | $823.95K |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |